Penumbra price target raised to $335 from $330 at UBS

UBS raised the firm’s price target on Penumbra (PEN) to $335 from $330 and keeps a Buy rating on the shares. Penumbra delivered another solid top- and bottom-line beat and sees the reiteration of U.S. thrombectomy guidance as largely predicated on weakness in U.S. Neuro and lack of visibility into market dynamics, the analyst tells investors in a research note. UBS continues to have high conviction in Penumbra.